{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:58:56Z","timestamp":1791575936381,"version":"4.3.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T00:00:00Z","timestamp":1513814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T00:00:00Z","timestamp":1513814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Protein:protein interactions are among the most difficult to treat molecular mechanisms of disease pathology. Cystine-dense peptides have the potential to disrupt such interactions, and are used in drug-like roles by every clade of life, but their study has been hampered by a reputation for being difficult to produce, owing to their complex disulfide connectivity. Here we describe a platform for identifying target-binding cystine-dense peptides using mammalian surface display, capable of interrogating high quality and diverse scaffold libraries with verifiable folding and stability. We demonstrate the platform\u2019s capabilities by identifying a cystine-dense peptide capable of inhibiting the YAP:TEAD interaction at the heart of the oncogenic Hippo pathway, and possessing the potency and stability necessary for consideration as a drug development candidate. This platform provides the opportunity to screen cystine-dense peptides with drug-like qualities against targets that are implicated for the treatment of diseases, but are poorly suited for conventional approaches.<\/jats:p>","DOI":"10.1038\/s41467-017-02098-8","type":"journal-article","created":{"date-parts":[[2017,12,15]],"date-time":"2017-12-15T18:20:45Z","timestamp":1513362045000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1142-9748","authenticated-orcid":false,"given":"Zachary R.","family":"Crook","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory P.","family":"Sevilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Della","family":"Friend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3950-1614","authenticated-orcid":false,"given":"Mi-Youn","family":"Brusniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok D.","family":"Bandaranayake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2402-108X","authenticated-orcid":false,"given":"Midori","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mesfin","family":"Gewe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9206-3150","authenticated-orcid":false,"given":"Andrew J.","family":"Mhyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland K.","family":"Strong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,21]]},"reference":[{"key":"2098_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrn1007","volume":"4","author":"C Soto","year":"2003","unstructured":"Soto, C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat. Rev. Neurosci. 4, 49\u201360 (2003).","journal-title":"Nat. Rev. Neurosci."},{"key":"2098_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","volume":"149","author":"CV Dang","year":"2012","unstructured":"Dang, C. V. MYC on the path to cancer. Cell 149, 22\u201335 (2012).","journal-title":"Cell"},{"key":"2098_CR3","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nrc3106","volume":"11","author":"Y Pylayeva-Gupta","year":"2011","unstructured":"Pylayeva-Gupta, Y., Grabocka, E. & Bar-Sagi, D. RAS oncogenes: weaving a tumorigenic web. Nat. Rev. Cancer 11, 761\u2013774 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"2098_CR4","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nrc3458","volume":"13","author":"KF Harvey","year":"2013","unstructured":"Harvey, K. F., Zhang, X. & Thomas, D. M. The Hippo pathway and human cancer. Nat. Rev. Cancer 13, 246\u2013257 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"2098_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1101\/gad.210773.112","volume":"27","author":"FXX Yu","year":"2013","unstructured":"Yu, F.-X. X. & Guan, K.-L. L. The Hippo pathway:regulators and regulations. Genes Dev. 27, 355\u2013371 (2013).","journal-title":"Genes Dev."},{"key":"2098_CR6","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.1002\/cncr.24495","volume":"115","author":"MZ Xu","year":"2009","unstructured":"Xu, M. Z. et al. Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer 115, 4576\u20134585 (2009).","journal-title":"Cancer"},{"key":"2098_CR7","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cell.2011.09.048","volume":"147","author":"M Cordenonsi","year":"2011","unstructured":"Cordenonsi, M. et al. The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell 147, 759\u2013772 (2011).","journal-title":"Cell"},{"key":"2098_CR8","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.humpath.2008.04.012","volume":"39","author":"AA Steinhardt","year":"2008","unstructured":"Steinhardt, A. A. et al. Expression of Yes-associated protein in common solid tumors. Hum. Pathol. 39, 1582\u20131589 (2008).","journal-title":"Hum. Pathol."},{"key":"2098_CR9","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1038\/onc.2010.606","volume":"30","author":"Z Zhou","year":"2011","unstructured":"Zhou, Z. et al. TAZ is a novel oncogene in non-small cell lung cancer. Oncogene 30, 2181\u20132186 (2011).","journal-title":"Oncogene"},{"key":"2098_CR10","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1038\/sj.bjc.6604774","volume":"99","author":"JF Knight","year":"2008","unstructured":"Knight, J. F. et al. TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer. Br. J. Cancer 99, 1849\u20131858 (2008).","journal-title":"Br. J. Cancer"},{"key":"2098_CR11","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1038\/onc.2011.379","volume":"31","author":"A Fernandez-L","year":"2012","unstructured":"Fernandez-L, A. et al. Oncogenic YAP promotes radioresistance and genomic instability in medulloblastoma through IGF2-mediated Akt activation. Oncogene 31, 1923\u20131937 (2012).","journal-title":"Oncogene"},{"key":"2098_CR12","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.semcdb.2012.05.004","volume":"23","author":"W Hong","year":"2012","unstructured":"Hong, W. & Guan, K.-L. The YAP and TAZ transcription co-activators: Key downstream effectors of the mammalian Hippo pathway. Semin. Cell. Dev. Biol. 23, 785\u2013793 (2012).","journal-title":"Semin. Cell. Dev. Biol."},{"key":"2098_CR13","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.1021\/jm501615v","volume":"58","author":"M Santucci","year":"2015","unstructured":"Santucci, M. et al. The hippo pathway and YAP\/TAZ\u2013TEAD protein\u2013protein interaction as targets for regenerative medicine and cancer treatment. J. Med. Chem. 58, 4857\u20134873 (2015).","journal-title":"J. Med. Chem."},{"key":"2098_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fcell.2017.00010","volume":"5","author":"JR Whitfield","year":"2017","unstructured":"Whitfield, J. R., Beaulieu, M.-E. & Soucek, L. Strategies to inhibit Myc and their clinical applicability. Front. Cell Dev. Biol. 5, 10 (2017).","journal-title":"Front. Cell Dev. Biol."},{"key":"2098_CR15","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nrd4389","volume":"13","author":"AD Cox","year":"2014","unstructured":"Cox, A. D., Fesik, S. W., Kimmelman, A. C., Luo, J. & Der, C. J. Drugging the undruggable RAS: Mission possible? Nat. Rev. Drug. Discov. 13, 828\u2013851 (2014).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"2098_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.coph.2016.05.002","volume":"29","author":"F Zanconato","year":"2016","unstructured":"Zanconato, F., Battilana, G., Cordenonsi, M. & Piccolo, S. YAP\/TAZ as therapeutic targets in cancer. Curr. Opin. Pharmacol. 29, 26\u201333 (2016).","journal-title":"Curr. Opin. Pharmacol."},{"key":"2098_CR17","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/aps.2011.14","volume":"32","author":"Q Nie","year":"2011","unstructured":"Nie, Q., Du, X. & Geng, M. Small molecule inhibitors of amyloid \u03b2 peptide aggregation as a potential therapeutic strategy for Alzheimer\u2019s disease. Acta Pharmacol. Sin. 32, 545\u2013551 (2011).","journal-title":"Acta Pharmacol. Sin."},{"key":"2098_CR18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.bcp.2013.12.008","volume":"88","author":"CM Wischik","year":"2014","unstructured":"Wischik, C. M., Harrington, C. R. & Storey, J. M. D. Tau-aggregation inhibitor therapy for Alzheimer\u2019s disease. Biochem. Pharmacol. 88, 529\u2013539 (2014).","journal-title":"Biochem. Pharmacol."},{"key":"2098_CR19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.5607\/en.2014.23.1.36","volume":"23","author":"S Kim","year":"2014","unstructured":"Kim, S. & Kim, K.-T. Therapeutic approaches for inhibition of protein aggregation in Huntington\u2019s disease. Exp. Neurobiol. 23, 36\u201344 (2014).","journal-title":"Exp. Neurobiol."},{"key":"2098_CR20","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1158\/0008-5472.CAN-06-2531","volume":"67","author":"MS Dennis","year":"2007","unstructured":"Dennis, M. S. et al. Imaging tumors with an albumin-binding Fab, a novel tumor-targeting agent. Cancer Res. 67, 254\u2013261 (2007).","journal-title":"Cancer Res."},{"key":"2098_CR21","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1042\/BST0391437","volume":"39","author":"A Scott","year":"2011","unstructured":"Scott, A., Weldon, S. & Taggart, C. C. SLPI and elafin: multifunctional antiproteases of the WFDC family. Biochem. Soc. Trans. 39, 1437\u20131440 (2011).","journal-title":"Biochem. Soc. Trans."},{"key":"2098_CR22","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S0300-9084(00)01167-6","volume":"82","author":"LD Possani","year":"2000","unstructured":"Possani, L. D., Merino, E., Corona, M., Bolivar, F. & Becerril, B. Peptides and genes coding for scorpion toxins that affect ion-channels. Biochimie 82, 861\u2013868 (2000).","journal-title":"Biochimie"},{"key":"2098_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/bcp.12932","volume":"83","author":"B Molesini","year":"2017","unstructured":"Molesini, B., Treggiari, D., Dalbeni, A., Minuz, P. & Pandolfini, T. Plant cystine-knot peptides: pharmacological perspectives. Br. J. Clin. Pharmacol. 83, 63\u201370 (2017).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"2098_CR24","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.bbamem.2006.02.007","volume":"1758","author":"S Boisseau","year":"2006","unstructured":"Boisseau, S. et al. Cell penetration properties of maurocalcine, a natural venom peptide active on the intracellular ryanodine receptor. Biochim. Biophys. Acta. 1758, 308\u2013319 (2006).","journal-title":"Biochim. Biophys. Acta."},{"key":"2098_CR25","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.3390\/ph3041093","volume":"3","author":"GB Gurrola","year":"2010","unstructured":"Gurrola, G. B., Capes, E. M., Zamudio, F. Z., Possani, L. D. & Valdivia, H. H. Imperatoxin A, a cell-penetrating peptide from scorpion venom, as a probe of Ca2\u2009+\u2009-release channels\/ryanodine receptors. Pharmaceuticals 3, 1093\u20131107 (2010).","journal-title":"Pharmaceuticals"},{"key":"2098_CR26","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/imr.12390","volume":"270","author":"R Mazor","year":"2016","unstructured":"Mazor, R., Onda, M. & Pastan, I. Immunogenicity of therapeutic recombinant immunotoxins. Immunol. Rev. 270, 152\u2013164 (2016).","journal-title":"Immunol. Rev."},{"key":"2098_CR27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cbpa.2016.08.022","volume":"34","author":"JR Kintzing","year":"2016","unstructured":"Kintzing, J. R. & Cochran, J. R. Engineered knottin peptides as diagnostics, therapeutics, and drug delivery vehicles. Curr. Opin. Chem. Biol. 34, 143\u2013150 (2016).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"2098_CR28","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/prot.22441","volume":"77","author":"RH Kimura","year":"2009","unstructured":"Kimura, R. H., Levin, A. M., Cochran, F. V. & Cochran, J. R. Engineered cystine knot peptides that bind \u03b1v\u03b23, \u03b1v\u03b25, and \u03b15\u03b21 integrins with low-nanomolar affinity. Proteins Struct. Funct. Bioinforma. 77, 359\u2013369 (2009).","journal-title":"Proteins Struct. Funct. Bioinforma."},{"key":"2098_CR29","doi-asserted-by":"publisher","first-page":"e76956","DOI":"10.1371\/journal.pone.0076956","volume":"8","author":"B Glotzbach","year":"2013","unstructured":"Glotzbach, B. et al. Combinatorial optimization of cystine-knot peptides towards high-affinity inhibitors of human matriptase-1. PLoS ONE. 8, e76956 (2013).","journal-title":"PLoS ONE."},{"key":"2098_CR30","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature19791","volume":"538","author":"G Bhardwaj","year":"2016","unstructured":"Bhardwaj, G. et al. Accurate de novo design of hyperstable constrained peptides. Nature 538, 329\u2013335 (2016).","journal-title":"Nature"},{"key":"2098_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-016-1350-9","volume":"17","author":"DT Barkan","year":"2016","unstructured":"Barkan, D. T. et al. Clustering of disulfide-rich peptides provides scaffolds for hit discovery by phage display: application to interleukin-23. BMC Bioinformatics 17, 481 (2016).","journal-title":"BMC Bioinformatics"},{"key":"2098_CR32","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nbt0697-553","volume":"15","author":"ET Boder","year":"1997","unstructured":"Boder, E. T. & Wittrup, K. D. Yeast surface display for screening combinatorial polypeptide libraries. Nat. Biotechnol. 15, 553\u2013557 (1997).","journal-title":"Nat. Biotechnol."},{"key":"2098_CR33","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1367-5931(00)00128-9","volume":"4","author":"KJ Woycechowsky","year":"2000","unstructured":"Woycechowsky, K. J. & Raines, R. T. Native disulfide bond formation in proteins. Curr. Opin. Chem. Biol. 4, 533\u2013539 (2000).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"2098_CR34","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1093\/nar\/gkr706","volume":"39","author":"AD Bandaranayake","year":"2011","unstructured":"Bandaranayake, A. D. et al. Daedalus: a robust, turnkey platform for rapid production of decigram quantities of active recombinant proteins in human cell lines using novel lentiviral vectors. Nucleic Acids Res. 39, e143 (2011).","journal-title":"Nucleic Acids Res."},{"key":"2098_CR35","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1006\/jmbi.1999.3130","volume":"292","author":"EV Shusta","year":"1999","unstructured":"Shusta, E. V., Kieke, M. C., Parke, E., Kranz, D. M. & Wittrup, K. D. Yeast polypeptide fusion surface display levels predict thermal stability and soluble secretion efficiency. J. Mol. Biol. 292, 949\u2013956 (1999).","journal-title":"J. Mol. Biol."},{"key":"2098_CR36","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/pro.2029","volume":"21","author":"S Ahmad","year":"2012","unstructured":"Ahmad, S., Kumar, V., Ramanand, K. B. & Rao, N. M. Probing protein stability and proteolytic resistance by loop scanning: a comprehensive mutational analysis. Protein Sci. 21, 433\u2013446 (2012).","journal-title":"Protein Sci."},{"key":"2098_CR37","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1126\/science.aan0693","volume":"357","author":"GJ Rocklin","year":"2017","unstructured":"Rocklin, G. J. et al. Global analysis of protein folding using massively parallel design, synthesis, and testing. Science 357, 168\u2013175 (2017).","journal-title":"Science"},{"key":"2098_CR38","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2098_CR39","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3109\/07388551.2015.1084266","volume":"36","author":"J Dumont","year":"2016","unstructured":"Dumont, J., Euwart, D., Mei, B., Estes, S. & Kshirsagar, R. Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives. Crit. Rev. Biotechnol. 36, 1110\u20131122 (2016).","journal-title":"Crit. Rev. Biotechnol."},{"key":"2098_CR40","doi-asserted-by":"publisher","first-page":"e20352","DOI":"10.7554\/eLife.20352","volume":"5","author":"S Berger","year":"2016","unstructured":"Berger, S. et al. Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancer. Elife 5, e20352 (2016).","journal-title":"Elife"},{"key":"2098_CR41","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.cell.2014.04.034","volume":"157","author":"E Procko","year":"2014","unstructured":"Procko, E. et al. A computationally designed inhibitor of an Epstein-Barr viral Bcl-2 protein induces apoptosis in infected cells. Cell 157, 1644\u20131656 (2014).","journal-title":"Cell"},{"key":"2098_CR42","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1096\/fj.14-262980","volume":"29","author":"Z Zhou","year":"2015","unstructured":"Zhou, Z. et al. Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides. Faseb. J. 29, 724\u2013732 (2015).","journal-title":"Faseb. J."},{"key":"2098_CR43","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1101\/gad.1865810","volume":"24","author":"Z Li","year":"2010","unstructured":"Li, Z. et al. Structural insights into the YAP and TEAD complex. Genes Dev. 24, 235\u2013240 (2010).","journal-title":"Genes Dev."},{"key":"2098_CR44","doi-asserted-by":"publisher","first-page":"340","DOI":"10.2174\/138920311796391124","volume":"12","author":"KS Bateman","year":"2011","unstructured":"Bateman, K. S. & James, M. N. G. Plant protein proteinase inhibitors: structure and mechanism of inhibition. Curr. Protein Pept. Sci. 12, 340\u2013347 (2011).","journal-title":"Curr. Protein Pept. Sci."},{"key":"2098_CR45","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.jmb.2008.11.004","volume":"385","author":"AP Silverman","year":"2009","unstructured":"Silverman, A. P., Levin, A. M., Lahti, J. L. & Cochran, J. R. Engineered cystine-knot peptides that bind \u03b1v\u03b23 integrin with antibody-like affinities. J. Mol. Biol. 385, 1064\u20131075 (2009).","journal-title":"J. Mol. Biol."},{"key":"2098_CR46","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nmeth.2998","volume":"11","author":"A Erazo-Oliveras","year":"2014","unstructured":"Erazo-Oliveras, A. et al. Protein delivery into live cells by incubation with an endosomolytic agent. Nat. Methods 11, 861\u2013867 (2014).","journal-title":"Nat. Methods"},{"key":"2098_CR47","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nbt0502-473","volume":"20","author":"S Fredriksson","year":"2002","unstructured":"Fredriksson, S. et al. Protein detection using proximity-dependent DNA ligation assays. Nat. Biotechnol. 20, 473\u2013477 (2002).","journal-title":"Nat. Biotechnol."},{"key":"2098_CR48","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/abbs\/gmq055","volume":"42","author":"Y Zhou","year":"2010","unstructured":"Zhou, Y. et al. A novel strategy for rapid construction of libraries of full-length antibodies highly expressed on mammalian cell surfaces. Acta Biochim. Biophys. Sin. 42, 575\u2013584 (2010).","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"2098_CR49","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ymeth.2013.06.010","volume":"65","author":"PM Bowers","year":"2014","unstructured":"Bowers, P. M. et al. Mammalian cell display for the discovery and optimization of antibody therapeutics. Methods 65, 44\u201356 (2014).","journal-title":"Methods"},{"key":"2098_CR50","first-page":"69","volume":"63","author":"HF Gilbert","year":"1990","unstructured":"Gilbert, H. F. Molecular and cellular aspects of thiol-disulfide exchange. Adv. Enzymol. Relat. Areas Mol. Biol. 63, 69\u2013172 (1990).","journal-title":"Adv. Enzymol. Relat. Areas Mol. Biol."},{"key":"2098_CR51","doi-asserted-by":"publisher","first-page":"16010","DOI":"10.1074\/jbc.272.25.16010","volume":"272","author":"E Viv\u00e8s","year":"1997","unstructured":"Viv\u00e8s, E., Brodin, P. & Lebleu, B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272, 16010\u20137 (1997).","journal-title":"J. Biol. Chem."},{"key":"2098_CR52","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1034\/j.1399-3011.2000.00723.x","volume":"56","author":"DJ Mitchell","year":"2000","unstructured":"Mitchell, D. J., Kim, D. T., Steinman, L., Fathman, C. G. & Rothbard, J. B. Polyarginine enters cells more efficiently than other polycationic homopolymers. J. Pept. Res. 56, 318\u2013325 (2000).","journal-title":"J. Pept. Res."},{"key":"2098_CR53","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1021\/bi0518390","volume":"45","author":"S Balayssac","year":"2006","unstructured":"Balayssac, S. et al. Comparison of penetratin and other homeodomain-derived cell-penetrating peptides: interaction in a membrane-mimicking environment and cellular uptake efficiency. Biochemistry 45, 1408\u20131420 (2006).","journal-title":"Biochemistry"},{"key":"2098_CR54","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.chembiol.2012.05.022","volume":"19","author":"JS Appelbaum","year":"2012","unstructured":"Appelbaum, J. S. et al. arginine topology controls escape of minimally cationic proteins from early endosomes to the cytoplasm. Chem. Biol. 19, 819\u2013830 (2012).","journal-title":"Chem. Biol."},{"key":"2098_CR55","doi-asserted-by":"publisher","first-page":"19518","DOI":"10.3390\/ijms160819518","volume":"16","author":"H Li","year":"2015","unstructured":"Li, H., Tsui, T. Y. & Ma, W. Intracellular delivery of molecular cargo using cell-penetrating peptides and the combination strategies. Int. J. Mol. Sci. 16, 19518\u201319536 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"2098_CR56","doi-asserted-by":"publisher","first-page":"D204","DOI":"10.1093\/nar\/gku989","volume":"43","author":"UniProt Consortium.","year":"2015","unstructured":"UniProt Consortium. UniProt: a hub for protein information. Nucleic Acids Res. 43, D204\u2013D212 (2015).","journal-title":"Nucleic Acids Res."},{"key":"2098_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-6-48","volume":"6","author":"RDM Page","year":"2005","unstructured":"Page, R. D. M. A Taxonomic Search Engine: federating taxonomic databases using web services. BMC Bioinformatics 6, 48 (2005).","journal-title":"BMC Bioinformatics"},{"key":"2098_CR58","doi-asserted-by":"publisher","first-page":"e1003639","DOI":"10.1371\/journal.ppat.1003639","volume":"9","author":"KAK Finton","year":"2013","unstructured":"Finton, K. A. K. et al. Autoreactivity and exceptional CDR Plasticity (but not unusual polyspecificity) hinder elicitation of the anti-HIV antibody 4E10. PLoS Pathog. 9, e1003639 (2013).","journal-title":"PLoS Pathog."},{"key":"2098_CR59","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s10529-011-0589-5","volume":"33","author":"GY Kim","year":"2011","unstructured":"Kim, G.-Y., Moon, J.-M., Han, J.-H., Kim, K.-H. & Rhim, H. The sCMV IE enhancer\/promoter system for high-level expression and efficient functional studies of target genes in mammalian cells and zebrafish. Biotechnol. Lett. 33, 1319\u20131326 (2011).","journal-title":"Biotechnol. Lett."},{"key":"2098_CR60","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.pep.2011.10.001","volume":"81","author":"SP Santos","year":"2012","unstructured":"Santos, S. P. et al. Thermofluor-based optimization strategy for the stabilization and crystallization of Campylobacter jejuni desulforubrerythrin. Protein Expr. Purif. 81, 193\u2013200 (2012).","journal-title":"Protein Expr. Purif."}],"updated-by":[{"DOI":"10.1038\/s41467-018-03350-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T00:00:00Z","timestamp":1520553600000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-02098-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-02098-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-02098-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T23:37:46Z","timestamp":1671752266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-02098-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,21]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["2098"],"URL":"https:\/\/doi.org\/10.1038\/s41467-017-02098-8","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41467-018-03350-5","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,21]]},"assertion":[{"value":"4 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2018","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original version of this Article the colour key for the amino acid enrichment score was inadvertently omitted from the lower panel of Figure 5b during the production process. This has now been corrected in the PDF and HTML versions of the Article.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Z.R.C., M.G., R.K.S., P.B., and J.M.O. are listed as authors on patent filings related to technology described in this work. J.M.O. is a founder and shareholder of Blaze Bioscience, Inc. The remaining authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2244"}}